Asembia’s Specialty Pharmacy Summit

Panelist says insights into the needs of particular populations of patients can help.

Members of a panel discussion on market access at Asembia’s specialty pharmacy meeting shared advise and insights into how best win acceptance and improve uptake of new products.

George Van Antwerp, pharmacy and PBM leader of Deloitte, presents at the Asembia 2021 Specialty Pharmacy Summit and shares framework of specialty pharmacy.

Steve Peskin of Horizon BCBS of NJ, executive medical director of Population Health at Horizon Blue Cross Blue Shield of New Jersey, shares forms of value-based contracting between payers and pharmaceutical companies.

Lance Grady, head of Market Access at Avalere Health, gives a preview of his presentation he gives at Asembia and discusses the significant changes made to specialty pharmacy because of the COVID-19 public health emergency.

Pharma industry experts Adam Fein, Ph.D., and Doug Long, MBA, described the growth of specialty pharmacy and the competition for that part of the pharma market during the opening presentation today at the Asembia 2021 Specialty Pharmacy Summit in Las Vegas.